2'-Fucosyllactose
CAS 41263-94-9
2'-Fucosyllactose (CAS 41263-94-9) is a Phase 1 pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Clinical Development Phase
Highest clinical development phase rendered from the matched compound identifier rows.
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is 2'-Fucosyllactose used for in pharmaceutical contexts?
2'-Fucosyllactose (CAS 41263-94-9) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for 2'-Fucosyllactose?
No adverse-event association or SIDER side-effect rows are rendered for 2'-Fucosyllactose in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is 2'-Fucosyllactose also used in cosmetics?
No same-CAS cosmetics profile is rendered from the ingredients-table cross-reference for 2'-Fucosyllactose.
What clinical phase is 2'-Fucosyllactose in?
2'-Fucosyllactose is rendered with ChEMBL max phase 1.